Latest news
Rising measles cases highlight gaps in vaccination coverage and public health system vulnerabilities
The Global Virus Network (GVN) is closely monitoring a significant resurgence of measles in the United States and globally, reflecting a growing vulnerability in public health systems.
CDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
Early immune responses linked to protective HIV antibodies
In a new study of broadly neutralizing antibodies and their potential for an HIV vaccine, researchers analyzed fragments of cell-free RNA and DNA circulating in the blood. This makes it possible to track immune responses, viral genetic variation, and other microbes from the same blood sample.
New research reveals cell proteins that drive severe viral infections
Researchers have identified two human cell proteins, NUP98 and NUP153, that play a crucial role in how viruses such as tick-borne encephalitis virus (TBEV), West Nile virus, and dengue virus replicate in the body.
Millions suffering needlessly with curable hepatitis C, new analysis reveals
Millions of Americans are still battling potentially deadly hepatitis C even though they could be cured with antiviral drugs they are not receiving, a new analysis reveals.
Has life-saving HIV therapy contributed to increased rates of a sexually transmitted disease?
A study has uncovered an unintended consequence of a major medical breakthrough: while the availability of HIV treatments in the late 1990s dramatically improved survival, they also contributed to a resurgence in syphilis, a sexually transmitted infection.
Early immune responses linked to protective HIV antibodies
In a new study of broadly neutralizing antibodies and their potential for an HIV vaccine, researchers analyzed fragments of cell-free RNA and DNA circulating in the blood. This makes it possible to track immune responses, viral genetic variation, and other microbes from the same blood sample.
New research reveals cell proteins that drive severe viral infections
Researchers have identified two human cell proteins, NUP98 and NUP153, that play a crucial role in how viruses such as tick-borne encephalitis virus (TBEV), West Nile virus, and dengue virus replicate in the body.
Millions suffering needlessly with curable hepatitis C, new analysis reveals
Millions of Americans are still battling potentially deadly hepatitis C even though they could be cured with antiviral drugs they are not receiving, a new analysis reveals.
CDI breakthroughs lead to new drug development deal for deadly NTM bacteria
Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
World-first shoe made entirely from pure mycelium unveiled at Milan Design Week
A prototype shoe made entirely from pure mycelium, the root-like network of fungi, will debut at Milan Design Week. The project is a collaboration between researcher and designer Lars Dittrich of Vrije Universiteit Brussel and head shoemaker Marie De Ryck at La Monnaie/De Munt.
Plastic texturing kills viruses when they land
Researchers have developed a thin plastic film that tears apart viruses on contact, offering a promising new way to keep high touch surfaces such as smartphones and hospital equipment from spreading disease.
New biosensor for detecting active tuberculosis
A research team is developing a sensor that paves the way for the rapid, selective and cost-effective detection of active tuberculosis. The device detects the presence of a protein secreted by Mycobacterium tuberculosis, the bacterium that causes the disease.
Rising measles cases highlight gaps in vaccination coverage and public health system vulnerabilities
The Global Virus Network (GVN) is closely monitoring a significant resurgence of measles in the United States and globally, reflecting a growing vulnerability in public health systems.
Studying two very different viruses helps to develop new strategies
When the SARS-CoV-2 pandemic began, virologist Theodora Hatziioannou, in conjunction with Paul Bieniasz brought her HIV-honed skills and tools to this new global threat, which made it easier and faster for researchers to gain insights into the virus and test antibodies for potential therapeutic candidates in real time.
Three European countries reach 90% HPV vaccination target as Europe steps up action on cancer prevention
All EU/EEA countries now recommend HPV vaccination for adolescent girls and boys as part of their immunisation programmes, marking a major step forward in Europe’s’ cancer prevention efforts. Iceland, Portugal and Norway have reached the target of 90% HPV vaccination coverage among girls by the age of 15.